Defining beta-interferon treatment failure in relapsing-remitting multiple sclerosis: clinical predictors of progressive disability

被引：0
|
作者：
O'Rourke, K [1 ]
Hutchinson, M [1 ]
机构：
[1] St Vincents Univ Hosp, Dublin, Ireland
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S6 / S7
页数：2
相关论文
共 50 条
  • [1] Predicting beta-interferon failure in relapsing-remitting multiple sclerosis
    O'Rourke, K.
    Walsh, C.
    Antonelli, G.
    Hutchinson, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (03) : 336 - 342
  • [2] Excerbations predict treatment failure in relapsing-remitting multiple sclerosis patients treated with beta-interferon
    Coret, E
    Bosca, I
    Pascual, A
    Landete, L
    Valero, C
    Casanova, B
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 45 - 46
  • [3] Impact of beta-interferon on disability progression in relapsing-remitting multiple sclerosis: a Bayesian analysis
    O'Rourke, K.
    Walsh, C.
    Hutchinson, M.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 102 - 103
  • [4] Outcome of beta-interferon treatment in relapsing-remitting multiple sclerosis: a Bayesian analysis
    K. O'Rourke
    C. Walsh
    M. Hutchinson
    [J]. Journal of Neurology, 2007, 254 : 1547 - 1554
  • [5] Outcome of beta-interferon treatment in relapsing-remitting multiple sclerosis: a Bayesian analysis
    O'Rourke, Killian
    Walsh, Cathal
    Hutchinson, Michael
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (11) : 1547 - 1554
  • [6] Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis
    Greenberg, Benjamin M.
    Balcer, Laura
    Calabresi, Peter A.
    Cree, Bruce
    Cross, Anne
    Frohman, Teresa
    Gold, Ralf
    Havrdova, Eva
    Hemmer, Bernhard
    Kieseier, Bernd C.
    Lisak, Robert
    Miller, Aaron
    Racke, Michael K.
    Steinman, Lawrence
    Stuve, Olaf
    Wiendl, Heinz
    Frohman, Elliot
    [J]. JAMA NEUROLOGY, 2013, 70 (02) : 248 - 251
  • [7] Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
    Drulovic, Jelena
    Kostic, Jelena
    Mesaros, Sarlota
    Basuroski, Irena Dujmovic
    Stojsavljevic, Nebojsa
    Kisic-Tepavcevic, Darija
    Pekmezovic, Tatjana
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S65 - S69
  • [8] Validity of MRI measures as surrogate markers in clinical trials of beta-interferon in relapsing-remitting multiple sclerosis
    Tremlett, H
    Traboulsee, A
    Li, D
    Paty, D
    [J]. NEUROLOGY, 2004, 62 (07) : A292 - A293
  • [9] Clinical predictors of disability in treatment-naive relapsing-remitting multiple sclerosis patients
    Ivaniuk, A.
    Solodovnikova, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 921 - 921
  • [10] The use of interferon beta in relapsing-remitting multiple sclerosis
    Etheridge, LJ
    Beverley, DW
    Ferrie, C
    McManus, E
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) : 789 - 791
12345